New cancer imaging technique uses vitamin C to detect more aggressive tumours

August 4, 2011, Cancer Research UK

Cancer research UK scientists have developed a new imaging technique that uses vitamin C to detect cancers likely to be more aggressive or resistant to treatment, according to a study published in the Journal of the American Chemical Society.

The most aggressive cancers are those which are able to divide rapidly without levels of oxidative – a process which leads to destructive molecules called free radicals building up in the cell and causing DNA damage – becoming high enough to trigger cell death.

Antioxidants like vitamin C are involved in helping to prevent this damage, by mopping up rogue free radicals.

Studies show that boosting the levels of the enzymes involved in the antioxidant action of vitamin C is one way in which cells increase their capacity to withstand oxidative stress.

The vitamin C inside a cell exists in a different form from that in the blood stream, and is converted from one to the other by enzymes found inside the cell.

Looking at lymphoma cancer cells in the lab and then in mice, the researchers were able to develop specially labelled versions of the two vitamin C forms and use these to detect tumours capable of dealing with higher levels of oxidative stress, which may be more resistant to chemotherapy.

Lead researcher Dr Sarah Bohndiek, based at Cancer Research UK’s Cambridge Research Institute, said: “This is the first time we've been able to show that can be used as a marker for imaging regions of high levels of oxidative stress in the body. This not only helps identify tumours more likely to be aggressive or resistant to treatment, it could also provide an accurate means of monitoring treatment response.

“Importantly, oxidative stress is also associated with other neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, meaning this technique could also have wider applications. Clinical trials exploring how this new imaging technique can be used in the clinic are already planned for the near future.”

This was developed in conjunction with GE Healthcare. Jonathan A. Murray, general manager for Metabolic Imaging at GE Healthcare, said: “GE’s Metabolic imaging technology continues to enable wonderful biochemical discovery, we are delighted to collaborate with Cambridge.”

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: “We know that cancers capable of dealing with higher levels of oxidative stress are more likely to spread and be resistant to chemotherapy, but we don’t have an effective way of detecting this before treatment. New imaging techniques like this could help signal early on whether or not a drug is working, allowing doctors to better tailor treatments to a patient’s individual cancer.”

More information: J. Am. Chem. Soc., 2011, 133 (30), pp 11795–11801 DOI: 10.1021/ja2045925

Related Stories

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.